Wireless MR Infusion System Receives FDA 510(k) Clearance

MEDRAD announced that the Continuum Wireless version of its Continuum MR Infusion System has received U.S. Food and Drug Administration (FDA) 510(k) clearance. The new wireless option for control of medication infusion inside or outside the MR scan room will increase workflow efficiencies and throughput while enhancing clinician confidence.
Read >>

MEDRAD Installs First Intego™ PET Infusion System

MEDRAD announced today the first installation of its Intego PET Infusion System at the University of Pittsburgh, Hillman Cancer Center. To achieve this milestone, MEDRAD partnered with IBA Molecular... Find out more >>

Intego™ PET Infusion System Now 510(k) Cleared

The new Intego™ PET Infusion System is the first infusion system available in the United States to automate the FDG delivery process. Read more >>

MEDRAD and PETNET Solutions Partner for FDG Delivery

The agreement will enable health care providers to inject FDG for PET/CT imaging procedures in an innovative, new way. Full story >>

XDS™ Extravasation Detector Wins Medical Design Excellence Award

MEDRAD's XDS™ Extravasation Detector for the Stellant® CT Injection System has received a 2008 Medical Design Excellence Award® (MDEA). The XDS aids in the detection of leaking intravenous contrast media from the injection site into surrounding tissue during computed tomography (CT) diagnostic studies.

Get the whole story >>

MEDRAD Announces Completion of Subsequent Offering Period for Shares of Possis Medical

Leverkusen, Germany / Pittsburgh, PA, USA, April 2, 2008 – Bayer HealthCare affiliate MEDRAD, Inc., announced today the completion of its tender offer for the outstanding shares of common stock of Possis Medical, Inc. (Nasdaq: POSS).

More details >>